Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports

Our Views
Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports
Magazine
Store

About Swarajya

Swarajya is a publication by Kovai Media Private Limited.

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Participate

Contact Us
Write for us
Style Guide
Jobs

Stay Connected

johnson and johnson

Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder

Bhaswati Guha Majumder

Covid-19 vaccine (Representative image)

US Decision To Not Give Emergency Authorisation To Bharat Biotech’s Covaxin Has Nothing To Do With Its Efficacy

Covaxin Covid-19 vaccine (Pic Via Twitter)

Why Pfizer And Moderna CEOs Are Recommending Covid-19 Vaccine Boosters, And Why Some Experts Don't Agree Yet

Bhaswati Guha Majumder

Albert Bourla, Pfizer CEO. (Twitter)

Moderna And Johnson & Johnson May Participate In Yogi Govt's Global Tender To Procure 40 Million Covid Vaccine Doses

Covid-19 vaccine. (Representative image)

US FDA Recommends Pause On Johnson & Johnson's Single Dose Vaccine Following Blood Clot Cases

(A picture of vaccine vials from Johnson and Johnson)

All You Need To Know About Johnson & Johnson’s Covid-19 Vaccine Trial In India

Bhaswati Guha Majumder

(A picture of vaccine vials from Johnson and Johnson)

Big Pharma In Big Mess: A Crisis Of Credibility

Rajeev Srinivasan

(Bruno Glasch/Pixabay)

Troubles Haven’t Ended For Johnson & Johnson: Baby Shampoo Fails Watchdog’s Quality Tests

J&J’s baby shampoo (Photo from Johnson and Johnson website)

When Stocks Get ‘Powdered’: Johnson & Johnson In Damage-Control Mode Amid Panic-Driven $40 Billion Share Sell-Off

Johnson and Johnson’s baby powder. (Photo by Justin Sullivan/Getty Images)

Cancer-Causing Asbestos In Johnson & Johnson’s Baby Powder? India Set To Investigate Following Reuters Report

Johnson’s and Johnson’s Baby Powder. (Justin Sullivan/Getty Images)

Johnson & Johnson To Pay Compensation For Faulty Implants Following Government Order

(Photo by Justin Sullivan/Getty Images)

Get Swarajya in your inbox.